Overview
This study aims to evaluate real-world treatment modalities and their corresponding effectiveness and safety in Chinese patients with marginal zone lymphoma, while also exploratively analyzing patient characteristics and health-related quality of life.
Eligibility
Inclusion Criteria:
- Be diagnosed as MZL
- Meet the treatment indications for MZL
Exclusion Criteria:
- Any reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.